Myocardial cell injury or cardiomyopathy is associated with excessive inflammatory response and apoptosis of cardiac myocytes during sepsis. MicroRNA-23b (miR-23b) is a multifunctional miRNA that is considered to regulate immunosuppression in sepsis. The aim of this study was to examine the effect of miR-23b on cardiomyopathy induced by sepsis and to explore the potential mechanism involved. Sprague-Dawley rats were subjected to cecal ligation and puncture (CLP), and the level of miR-23b at different time points was measured by quantitative real-time polymerase chain reaction (qPCR). Then, we overexpressed miR-23b in vivo and in vitro. The rats were subjected to CLP 7 days after transfection. Cardiac function, inflammatory response, and heart tissues were examined 3 days thereafter. In an in vitro experiment, H9C2 cardiomyoblasts were stimulated with lipopolysaccharide (LPS) after transfection of miR-23b, following which apoptosis and the level of NF-κB were analyzed. The expression of miR-23b was upregulated during polymicrobial sepsis, and transfection of miR-23b lentivirus improved the outcome of sepsis-induced cardiomyopathy by attenuating inflammatory responses and protecting against histopathological damage. In in vitro experiments, elevated miR-23b inhibited excessive apoptosis of cardiomyocytes, which may be because activation of the NF-κB signaling pathway was inhibited by the decreased levels of TRAF6 and IKKβ. Therefore, miR-23b improved sepsis-induced cardiomyopathy by attenuating the inflammatory response, suppressing apoptosis, and preventing NF-κB activation via targeted inhibition of TRAF6 and IκκB. These results indicated that miR-23b may represent a novel therapeutic approach for clinical treatment of sepsis-induced cardiomyopathy.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
All data generated or analyzed during this study are included in this published article [and its supplementary information files].
Brain natriuretic peptide
Cecal ligation and puncture
Enzyme-linked immunosorbent assay
Electrophoretic mobility shift assay
Intercellular cell adhesion molecule 1
Migration inhibitory factor
Nuclear factor kappaB
Quantitative real-time polymerase chain reaction
- SIC :
Vascular cell adhesion molecule 1
Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G.R. Bernard, J.D. Chiche, C.M. Coopersmith, R.S. Hotchkiss, M.M. Levy, J.C. Marshall, G.S. Martin, S.M. Opal, G.D. Rubenfeld, T. van der Poll, J.L. Vincent, and D.C. Angus. 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). Journal of the American Medical Association 315: 801–810.
Gomez, E., M. Vercauteren, B. Kurtz, A. Ouvrard-Pascaud, P. Mulder, J.P. Henry, M. Besnier, A. Waget, R. Hooft Van Huijsduijnen, M.L. Tremblay, et al. 2012. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. Journal of Molecular and Cellular. 52 (6): 1257–1264.
Charpentier, J., C.E. Luyt, Y. Fulla, C. Vinsonneau, A. Cariou, S. Grabar, J.F. Dhainaut, J.P. Mira, and J.D. Chiche. 2004. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Critical Care Medicine 32 (3): 660–665.
Gille-Johnson, P., C. Smedman, L. Gudmundsdotter, A. Somell, K. Nihlmark, S. Paulie, J. Andersson, and B. Gårdlund. 2012. Circulating monocytes are not the major source of plasma cytokines in patients with sepsis. Shock 38 (6): 577–583.
Vieillard-Baron, A., V. Caille, C. Charron, G. Belliard, B. Page, and F. Jardin. 2008. Actual incidence of global left ventricular hypokinesia in adult septic shock. Critical Care Medicine 36 (6): 1701–1706.
Fleischmann, C., A. Scherag, N.K. Adhikari, C.S. Hartog, T. Tsaganos, P. Schlattmann, D.C. Angus, and K. Reinhart. 2016. International Forum of Acute Care Trialists: Assessment of global incidence and mortality of hospital-treated Sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193 (3): 259–272.
Micek, S.T., C. McEvoy, M. McKenzie, N. Hampton, J.A. Doherty, and M.H. Kollef. 2013. Fluid balance and cardiac function in septic shock as predictors of hospital mortality. Critical Care 17 (5): R246.
Antonucci, E., E. Fiaccadori, K. Donadello, F.S. Taccone, F. Franchi, and S. Scolletta. 2014. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. Journal of Critical Care 29 (4): 500–511.
Liu, Y.C., M.M. Yu, S.T. Shou, and Y.F. Chai. 2017. Sepsis-induced cardiomyopathy: mechanisms and treatments. Frontiers in Immunology 8 (1021).
Tsolaki, V., D. Makris, K. Mantzarlis, and E. Zakynthinos. 2017. Sepsis-induced cardiomyopathy: oxidative implications in the initiation and resolution of the damage. Oxidative Medicine and Cellular Longevity 2017: 7393525.
Suffredini, A.F., R.E. Fromm, M.M. Parker, M. Brenner, J.A. Kovacs, R.A. Wesley, and J.E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. The New England Journal of Medicine 321 (5): 280–287.
Mann, M., A. Mehta, J.L. Zhao, K. Lee, G.K. Marinov, Y. Garcia-Flores, and D. Baltimore. 2017. An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses. Nature Communications 8 (1): 851.
Cao, C., C. Yin, S. Shou, J. Wang, L. Yu, X. Li, and Y. Chai. 2018. Ulinastatin protects against LPS-induced acute lung injury by attenuating TLR4/NF-κB pathway activation and reducing inflammatory mediators. Shock 50 (5): 595–605.
Zou, L., Y. Feng, Y.J. Chen, R. Si, S. Shen, Q. Zhou, F. Ichinose, M. Scherrer-Crosbie, and W. Chao. 2010. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Critical Care Medicine 38 (5): 1335–1342.
Gao, M., T. Ha, X. Zhang, L. Liu, X. Wang, J. Kelley, K. Singh, R. Kao, X. Gao, D. Williams, et al. 2010. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Critical Care Medicine 40 (8): 2390–2399.
Gao, M., T. Ha, X. Zhang, X. Wang, L. Liu, J. Kalbfleisch, K. Singh, D. Williams, and C. Li. 2013. The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. The Journal of Infectious Diseases 207 (9): 1471–1479.
Melton, C., R.L. Judson, and R. Blelloch. 2010. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463 (7281): 621–626.
Dvinge, H., A. Git, S. Gräf, M. Salmon-Divon, C. Curtis, A. Sottoriva, Y. Zhao, M. Hirst, J. Armisen, E.A. Miska, S.F. Chin, E. Provenzano, G. Turashvili, A. Green, I. Ellis, S. Aparicio, and C. Caldas. 2013. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497 (7449): 378–382.
Amaral, A.E.D., M.P. Rode, J. Cisilotto, T.E.D. Silva, J. Fischer, C. Matiollo, E.C. Morais Rateke, J.L. Narciso-Schiavon, L.L. Schiavon, and T.B. Creczynski-Pasa. 2018. MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival. Pharmacological Research 134: 179–192.
Tacke, F., C. Roderburg, F. Benz, D.V. Cardenas, M. Luedde, H.J. Hippe, N. Frey, M. Vucur, J. Gautheron, A. Koch, C. Trautwein, and T. Luedde. 2014. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Critical Care Medicine 42 (5): 1096–1104.
Ge, C., J. Liu, and S. Dong. 2018. miRNA-214 protects sepsis-induced myocardial injury. Shock 50 (1): 112–118.
Ma, H., X. Wang, T. Ha, M. Gao, L. Liu, R. Wang, K. Yu, J.H. Kalbfleisch, R.L. Kao, D.L. Williams, and C. Li. 2016. MicroRNA-125b prevents cardiac dysfunction in polymicrobial sepsis by targeting TRAF6-mediated nuclear factor κB activation and p53-mediated apoptotic signaling. The Journal of Infectious Diseases 214 (11): 1773–1783.
Wang, H., Y. Bei, S. Shen, P. Huang, J. Shi, J. Zhang, Q. Sun, Y. Chen, Y. Yang, T. Xu, X. Kong, and J. Xiao. 2016. miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. Journal of Molecular and Cellular Cardiology 94: 43–53.
Grieco, F.A., G. Sebastiani, J. Juan-Mateu, O. Villate, L. Marroqui, L. Ladrière, K. Tugay, R. Regazzi, M. Bugliani, P. Marchetti, F. Dotta, and D.L. Eizirik. 2017. MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic BH3-only proteins DP5 and PUMA in human pancreatic β-cells. Diabetes 66 (1): 100–112.
Hu, R., and R.M. O’Connell. 2012. MiR-23b is a safeguard against autoimmunity. Nature Medicine 18 (7): 1009–1010, 2017.
Zheng, J., H.Y. Jiang, J. Li, H.C. Tang, X.M. Zhang, X.R. Wang, J.T. Du, H.B. Li, and G. Xu. 2012. MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-κB signalling pathways. Allergy 67 (3): 362–370.
Zhu, S., W. Pan, X. Song, Y. Liu, X. Shao, Y. Tang, D. Liang, D. He, H. Wang, W. Liu, Y. Shi, J.B. Harley, N. Shen, and Y. Qian. 2012. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nature Medicine 18 (7): 1077–1086.
Wu, M., J.T. Gu, B. Yi, Z.Z. Tang, and G.C. Tao. 2015. microRNA-23b regulates the expression of inflammatory factors in vascular endothelial cells during sepsis. Experimental and Therapeutic Medicine 9 (4): 1125–1132.
Hoyt, C.C., S.M. Richardson-Burns, R.J. Goody, B.A. Robinson, R.L. Debiasi, and K.L. Tyler. 2005. Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. Journal of Virology 79 (5): 2743–2753.
Cao, C., C. Yin, Y. Chai, H. Jin, L. Wang, and S. Shou. 2018. Ulinastatin mediates suppression of regulatory T cells through TLR4/NF-κB signaling pathway in murine sepsis. International Immunopharmacology 64: 411–423.
Hobai, I.A., J. Edgecomb, K. LaBarge, and W.S. Colucci. 2015. Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock 43 (1): 3–15.
Zhang, H., H.Y. Wang, R. Bassel-Duby, D.L. Maass, W.E. Johnston, J.W. Horton, and W. Tao. 2007. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. American Journal of Physiology. Heart and Circulatory Physiology 292 (5): H2408–H2416.
Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. The Journal of Clinical Investigation 107 (1): 13–19.
Sheehan, M., H.R. Wong, P.W. Hake, and B. Zingarelli. 2003. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Critical Care Medicine 31 (9): 2263–2270.
Zheng, Z., H. Ma, X. Zhang, F. Tu, X. Wang, T. Ha, M. Fan, L. Liu, J. Xu, K. Yu, R. Wang, J. Kalbfleisch, R. Kao, D. Williams, and C. Li. 2017. Enhanced glycolytic metabolism contributes to cardiac dysfunction in polymicrobial sepsis. The Journal of Infectious Diseases 215 (9): 1396–1406.
Brudecki, L., D.A. Ferguson, D. Yin, G.D. Lesage, C.E. McCall, and M. El Gazzar. 2012. Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis. Infection and Immunity 80 (2): 602–611.
Yoon, S.J., S.J. Kim, and S.M. Lee. 2017. Overexpression of HO-1 contributes to sepsis-induced immunosuppression by modulating the Th1/Th2 balance and regulatory T-cell function. The Journal of Infectious Diseases 215 (10): 1608–1618.
Zhang, H., Y. Caudle, A. Shaikh, B. Yao, and D. Yin. 2018. Inhibition of microRNA-23b prevents polymicrobial sepsis-induced cardiac dysfunction by modulating TGIF1 and PTEN. Biomedicine & Pharmacotherapy 103: 869–878.
Court, O., A. Kumar, J.E. Parrillo, and A. Kumar. 2002. Clinical review: Myocardial depression in sepsis and septic shock. Critical Care 6 (6): 500–508.
Chagnon, F., C.N. Metz, R. Bucala, and O. Lesur. 2005. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circulation Research 96 (10): 1095–1102.
Alves-Filho, J.C., A. de Freitas, F. Spiller, F.O. Souto, and C.Q. Cunha. 2008. The role of neutrophils in severe sepsis. Shock 30: 3–9.
Cavaillon, J.M., and M. Adib-Conquy. 2005. Monocytes/macrophages and sepsis. Critical Care Medicine 33: S506–S509.
O’Neill, L.A., F.J. Sheedy, and C.E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature Reviews. Immunology 11 (3): 163–175.
Williams, D.L., T. Ha, C. Li, J.H. Kalbfleisch, J. Schweitzer, W. Vogt, and I.W. Browder. 2003. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Critical Care Medicine 31 (6): 1808–1818.
Gao, M., X. Wang, X. Zhang, T. Ha, H. Ma, L. Liu, J.H. Kalbfleisch, X. Gao, R.L. Kao, D.L. Williams, and C. Li. 2015. Attenuation of cardiac dysfunction in polymicrobial sepsis by microRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression. Journal of Immunology 195 (2): 672–682.
Ha, T., C. Lu, L. Liu, F. Hua, Y. Hu, J. Kelley, K. Singh, R.L. Kao, J. Kalbfleisch, D.L. Williams, X. Gao, and C. Li. 2010. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. American Journal of Physiology. Heart and Circulatory Physiology 298 (3): H984–H991.
Medzhitov, R., P. Preston-Hurlburt, and C.A.J. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (6640): 394–397.
Nevière, R., H. Fauvel, C. Chopin, P. Formstecher, and P. Marchetti. 2001. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. American Journal of Respiratory and Critical Care Medicine 163 (1): 218–225.
This work was supported by the National Natural Science Foundation of China (Grant No. 81871593 to YFC), Theory E Emergency Medical Research Fund of China (Grant No. R2015026 to CC), and Tianjin Medical University General Hospital Fund of China (Grant No. ZYYFY2015010 to CC, ZYYFY2016026 to YZ).
The authors declare that they have no conflicts of interest.
Ethics Approval and Consent to Participate
All experimental manipulations were undertaken in accordance with the Guide for the Care and Use of Medical Laboratory Animals (Ministry of Health, P.R. China, 1998), with the approval of the Scientific Investigation Board, Tianjin Medical University General Hospital, Tianjin, China.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cao, C., Zhang, Y., Chai, Y. et al. Attenuation of Sepsis-Induced Cardiomyopathy by Regulation of MicroRNA-23b Is Mediated Through Targeting of MyD88-Mediated NF-κB Activation. Inflammation 42, 973–986 (2019). https://doi.org/10.1007/s10753-019-00958-7
- sepsis-induced cardiomyopathy
- inflammatory response